Search Results - "Magoon, M W"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Heterogeneity of alveolar surfactant in the rabbit: composition, morphology, and labelling of subfractions isolated by centrifugation of lung lavage by Baritussio, A, Bellina, L, Carraro, R, Rossi, A, Enzi, G, Magoon, M W, Mussini, I

    Published in European journal of clinical investigation (01-02-1984)
    “…Rabbit alveolar saturated phosphatidylcholine (SPC) can be separated by differential and density gradient centrifugation of lung lavage into three fractions…”
    Get more information
    Journal Article
  2. 2

    Delays in immunizations of high-risk infants during the first two years of life: special care for the high-risk infant should not mean special immunization schedules by Magoon, M W, Belardo, L J, Caldito, G

    Published in Journal of perinatology (01-05-1995)
    “…Because experience in our newborn intensive care unit follow-up clinic since 1982 suggested that immunizations of newborn intensive care unit graduates in the…”
    Get more information
    Journal Article
  3. 3

    Subfractionation of lung surfactant. Implications for metabolism and surface activity by Magoon, M W, Wright, J R, Baritussio, A, Williams, M C, Goerke, J, Benson, B J, Hamilton, R L, Clements, J A

    Published in Biochimica et biophysica acta (01-01-1983)
    “…Because previous studies have suggested that lung surfactant is not a simple compartment of homogeneous material, we subfractionated lamellar bodies and…”
    Get more information
    Journal Article
  4. 4

    Precursor-product relationship between rabbit type II cell lamellar bodies and alveolar surface-active material. Surfactant turnover time by Baritussio, A G, Magoon, M W, Goerke, J, Clements, J A

    Published in Biochimica et biophysica acta (23-12-1981)
    “…To estimate the turnover time of alveolar surfactant in New Zealand white rabbits, we injected [9,10-(3)H] palmitic acid and [2-(14)C] glycerol intravenously…”
    Get more information
    Journal Article
  5. 5

    Early Postnatal Dexamethasone Therapy for the Prevention of Chronic Lung Disease by The Vermont Oxford Network Steroid Study Group

    Published in Pediatrics (Evanston) (01-09-2001)
    “…To test the hypothesis that early postnatal dexamethasone will reduce the incidence of death or chronic lung disease (CLD) in ventilated extremely low birth…”
    Get full text
    Journal Article
  6. 6
  7. 7